Midtrimester abortion by dilatation and evacuation versus intra-amniotic instillation of prostaglandin F2α: A randomized clinical trial

American Journal of Obstetrics and Gynecology

Volumn 137, Issue 7, 1980, Pages 785-790

  Grimes, David A ^a   Hulka, Jaroslav F ^a   McCutchen, Mary E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN F2 ALPHA;

ABORTION; ADVERSE DRUG REACTION; CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DIGESTIVE SYSTEM; DRUG ADMINISTRATION; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAAMNIOTIC INJECTION; LAMINARIA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER ABORTION; SUCTION CURETTAGE; THERAPY; UTERINE CERVIX DILATATION;

EID: 0018972057     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(80)90886-8     Document Type: Article

References (16)

1. Second trimester abortion. A symposium by correspondence
2. The impact of midtrimester abortion techniques on patients and staff
3. Midtrimester abortion by dilatation and evacuation. A safe and practical alternative
4. Midtrimester abortion by dilatation and evacuation (letter)
5. Midtrimester abortion procedures (letter)
6. Are randomized trials appropriate for evaluating new operations?
7. The effect of delay and choice of method on the risk of abortion morbidity
8. Midtrimester dilatation and evacuation abortion
9. Mid-trimester abortion
10. 2α
11. Weight, sitting height, head size, foot length, and menstrual age of the human embryo
12. Simple interval-estimation of risk ratio
13. Methods of midtrimester abortion: Which is safest?
14. 2α-induced midtrimester abortion
15. Analysis of retained placenta associated with saline abortion: Clinical considerations
16. Laminaria as an adjunct in induction of labor